DrugDashboards

Guaifenesin and Codeine Phosphate

Guaifenesin and Codeine Phosphate · GUAIFENESIN 100 mg/5mL; CODEINE PHOSPHATE 10 mg/5mL · Solution · Oral · Preferred Pharmaceuticals Inc.

NDC 68788-8361-01 · 118 mL in 1 BOTTLE · OTC MONOGRAPH DRUG · View full market →

The short version

4 companies supply this market — a reasonable cushion if one runs into trouble.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

Medicare Part D does not cover over-the-counter drugs — by law it pays only for products requiring a prescription.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for guaifenesin and codeine phosphate (other) in the next 90 days

sole-source market · price up 5% YoY

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Regulatory

Application
MO12
TE code
Approval date
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Guaifenesin and Codeine Phosphate (Solution)

LabelerStrengthFirst seenLast seen
A-S Medication SolutionsGUAIFENESIN 100 mg/5mL; CODEINE PHOSPHATE 10 mg/5mLAug 26, 2026Sep 2, 2026
Cardinal Health 107, LLCCODEINE PHOSPHATE 10 mg/5mL; GUAIFENESIN 100 mg/5mLJul 15, 2026Sep 2, 2026
PAI Holdings, LLCGUAIFENESIN 200 mg/10mL; CODEINE PHOSPHATE 20 mg/10mLAug 26, 2026Sep 2, 2026
PAI Holdings, LLCGUAIFENESIN 100 mg/5mL; CODEINE PHOSPHATE 10 mg/5mLAug 26, 2026Sep 2, 2026
Preferred Pharmaceuticals Inc.GUAIFENESIN 100 mg/5mL; CODEINE PHOSPHATE 10 mg/5mLAug 26, 2026Sep 2, 2026
PAI Holdings, LLCGUAIFENESIN 10 mg/5mL; CODEINE PHOSPHATE 100 mg/5mLJul 22, 2026Aug 22, 2026
A-S Medication SolutionsGUAIFENESIN 10 mg/5mL; CODEINE PHOSPHATE 100 mg/5mLJul 22, 2026Aug 19, 2026
PAI Holdings, LLCGUAIFENESIN 20 mg/10mL; CODEINE PHOSPHATE 200 mg/10mLJul 22, 2026Aug 19, 2026
Preferred Pharmaceuticals Inc.GUAIFENESIN 10 mg/5mL; CODEINE PHOSPHATE 100 mg/5mLJul 22, 2026Aug 19, 2026
PAI Holdings, LLCCODEINE PHOSPHATE 10 mg/5mL; GUAIFENESIN 100 mg/5mLJul 15, 2026Jul 19, 2026
A-S Medication SolutionsCODEINE PHOSPHATE 10 mg/5mL; GUAIFENESIN 100 mg/5mLJul 15, 2026Jul 15, 2026
PAI Holdings, LLCCODEINE PHOSPHATE 20 mg/10mL; GUAIFENESIN 200 mg/10mLJul 15, 2026Jul 15, 2026
Preferred Pharmaceuticals Inc.CODEINE PHOSPHATE 10 mg/5mL; GUAIFENESIN 100 mg/5mLJul 15, 2026Jul 15, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Guaifenesin and Codeine Phosphate — NDC 68788-8361-01," retrieved September 3, 2026, https://drugdashboards.com/drug/68788836101.

Free to cite with attribution — see how the data is put together.